Strategic Partnerships MAC's collaborations with Initiator Pharma and Kariyapharma show a flexible early phase collaboration model, including a dedicated Manchester Early Phase Unit, appealing to sponsors seeking efficient Phase I and II studies and single centre capabilities.

Specialized Capabilities State of the art facilities including an MHRA accredited Early Phase Unit, a sleep laboratory, psychedelic testing suites, GMP facilities and a fully equipped laboratory enable sponsors to outsource complex Phase I to IV trials end to end.

Global Site Network A fully owned network of dedicated research sites and a global contracting capability positions MAC as a scalable partner for multinational trials, with UK presence and expertise to meet diverse trial requirements.

Sustainability Advantage EcoVadis Bronze status with high scores across Environment, Labor and Human Rights, Ethics and Sustainable Procurement provides ESG credibility, making MAC a potential partner for sponsors with sustainability mandates.

Thought Leadership Focused therapeutic areas including CNS, Mens and Womens Health, and Dermatology, combined with over thirty years of CRO experience and a growing thought leadership program through MAC Behind The Trials, support differentiation and ongoing engagement with prospective clients.